Comments on Cures 2.0 Discussion Draft
Honorable Diana DeGetteHonorable Fred Upton Comments on Cures 2.0 Discussion Draft Dear Representatives DeGette and Upton: Thank you for your...
Medicare Program; Medicare Coverage of Innovative Technology (MCIT) and Definition of “Reasonable and Necessary”; Delay of Effective Date (Docket No. CMS-2021-05490)
The Heart Valve Disease Policy Task Force represents a diverse group of patient,disease, and research advocacy groups with a shared...
HVVUS Expresses Thoughts On Medicare Coverage for Innovative Technologies
Heart Valve Voice US is a nonprofit patient advocacy organization that provides a united voicefor people living with heart valve...
HVV US is advocating for patients with mitral valve disease. See our comments to CMS
Telehealth offers significant advantages to patients of all types, including and especially older Americans with mobility and other age-associated health...
Need for Patient Input Regarding Resumption of Cardiovascular Procedures
To download this page as a PDF, click here. Heart Valve Voice US is deeply concerned that the patient perspective...
CMS Makes Progress but Continues to Limit Life-Saving Access for Heart Valve Disease Patients
Washington, D.C., March 27, 2019 – Below is a statement issued on behalf of the Alliance for Aging Research, Association of Black...